Capital transactions
from Series A to late-stage venture
M&A
Sell-side and Buy-side advisory services
Imactis sold to GE Healtchare
May 2023
Imactis came as a natural fit to the newly-independant GE HealthCare to enhance their capabilities in interventional guidance, particularly in CT-based procedures.
The IMACTIS CT-Navigation system, which offers precise needle guidance for complex procedures, helps GE HealthCare improve procedural accuracy, thus reducing time and minimizing radiation exposure.
For Imactis, it was compelling that GE HealthCare would scale the technology globally, making it a standard in minimally invasive procedures.
Exclusive financial advisers to the sellers
eCential Robotics' €100M Series B
March 2021
eCential Robotics raised €100 million to accelerate the development and commercialization of its innovative robotic platform for spine surgery.
This funding allows the company to expand its production capabilities, strengthen its market presence in Europe, and entering the North American market.
eCential Robotics aims to become a leader in digital and robotic surgery by offering a unified platform that integrates 2D/3D imaging, navigation, and robotic guidance, significantly improving surgical precision and patient outcomes.
Exclusive financial advisers to the company
Orthotaxy acquired by Johnson & Johnson
December 2018
In 2018, Johnson & Johnson acquired Orthotaxy, a French company developing a next-generation robotic-assisted surgery platform, particularly targeting total and partial knee replacements. This acquisition was a strategic move by Johnson & Johnson to integrate Orthotaxy's innovative technology into a comprehensive orthopaedic platform.
After the acquisition, Orthotaxy's technology became a key component of the Velys Robotic-Assisted Solution. The Velys solution, designed for use with the Attune Total Knee System, is part of the broader Velys Digital Surgery Platform.
Exclusive financial advisers to the sellers